Implementation and Outcome of Thrombolysis with Alteplase 3 to 4.5 h After Acute Stroke in Chinese Patients

BACKGROUND AND PURPOSE: The European Cooperative Acute Stroke Study (ECASS) III showed that intravenous recombinant tissue plasminogen activator (rtPA) administered in the 3 to 4.5 h after symptom onset significantly improved clinical outcomes in patients with acute ischemic stroke (AIS). But little...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:CNS Neurosci Ther
Autores principales: Liao, Xiao‐Ling, Wang, Chun‐Xue, Wang, Yi‐Long, Wang, Chun‐Juan, Zhao, Xing‐Quan, Zhang, Li‐Qun, Liu, Li‐Ping, Pan, Yue‐Song, Wang, Yong‐Jun
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2012
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6493566/
https://ncbi.nlm.nih.gov/pubmed/23206165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12031
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares